Objectives: Carisbamate (CRS) is a novel monocarbamate compound that possesses antiseizure and neuroprotective properties. However, the mechanisms underlying these actions remain unclear. Here, we tested both direct and indirect effects of CRS on several cellular systems that regulate intracellular calcium concentration [Ca 2+ ] i . Methods: We used a combination of cellular electrophysiologic techniques, as well as cell viability, Store Overload-Induced Calcium Release (SOICR), and mitochondrial functional assays to determine whether CRS might affect [Ca 2+ ] i levels through actions on the endoplasmic reticulum (ER), mitochondria, and/or T-type voltagegated Ca 2+ channels. Results: In CA3 pyramidal neurons, kainic acid induced significant elevations in [Ca 2+ ] i and long-lasting neuronal hyperexcitability, both of which were reversed in a dose-dependent manner by CRS. Similarly, CRS suppressed spontaneous rhythmic epileptiform activity in hippocampal slices exposed to zero-Mg 2+ or 4-aminopyridine. Treatment with CRS also protected murine hippocampal HT-22 cells against excitotoxic injury with glutamate, and this was accompanied by a reduction in [Ca 2+ ] i . Neither kainic acid nor CRS alone altered the mitochondrial membrane potential (DΨ) in intact, acutely isolated mitochondria. In addition, CRS did not affect mitochondrial respiratory chain activity, Ca 2+ -induced mitochondrial permeability transition, and Ca 2+ release from the ER. However, CRS significantly decreased Ca 2+ flux in human embryonic kidney tsA-201 cells transfected with Ca v 3.1 (voltage-dependent T-type Ca 2+ ) channels. Significance: Our data indicate that the neuroprotective and antiseizure activity of CRS likely results in part from decreased [Ca 2+ ] i accumulation through blockade of Ttype Ca 2+ channels.
• CRS blocked epileptiform activity in hippocampal slices exposed to zero-Mg 2+ or 4-AP
• CRS did not affect mitochondrial respiratory chain activity or Ca 2+ release from the endoplasmic reticulum
• CRS decreased Ca is an investigational compound that has shown broad-spectrum efficacy against seizures in animal models and appears to exert neuroprotective effects. 1 Clinically, CRS has been shown to be effective and well tolerated in patients with refractory focal-onset seizures. 2, 3 However, a larger phase III clinical trial failed to document significant seizure reduction over the dose range studied. 4 Notwithstanding these results, CRS has recently been shown to enhance behavior and cognition in a model of temporal lobe epilepsy (TLE), 5 suggesting possible usefulness in controlling comorbid symptoms of epilepsy.
Although earlier studies have demonstrated CRS blockade of voltage-gated sodium channels and action potential firing in hippocampal neurons, 6 ,7 the mechanisms accounting for the beneficial effects of CRS remain unclear. Recently, CRS was found to decrease glutamate and increase glutamine brain levels in the rat lithium-pilocarpine model of TLE, but these effects were not seen consistently. 8 Furthermore, electrophysiologic studies indicated that CRS reduces glutamatergic transmission by an action potential-dependent presynaptic mechanism. 9 Given these observations, and the fact that neuronal hyperexcitability can arise from excessive intracellular calcium [Ca 2+ ] i accumulation, we asked whether CRS might alter Ca 2+ homeostasis in hippocampal neurons, and tested both direct and indirect effects of CRS on the four major cellular systems that regulate calcium, namely cell membrane-bound glutamate receptors, voltage-gated calcium channels, mitochondria, and the endoplasmic reticulum (ER).
Methods
All experimental procedures were approved by the respective institutional animal care and use committees (IACUCs) where the relevant studies were conducted: Barrow Neurological Institute at St. Joseph's Hospital and Medical Center; the University of Kentucky (Lexington, KY, U.S.A.); and the University of Calgary (Calgary, AB, Canada).
Slice electrophysiology
Male C3HeB/FeJ wild-type mice (4-7 weeks old) were anesthetized with isoflurane. Following decapitation, the brain was isolated and then submerged in ice-cold oxygenated physiologic saline (124 mM NaCl, 1.8 mM MgSO 4 , 4 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 2.4 mM CaCl 2 , and 10 mM D-glucose, [pH = 7.4]). Transverse hippocampal brain slices (300 lm) were cut using a vibratome and transferred to a perfusion chamber mounted on an Axioskop FS2 microscope (Carl Zeiss, Thornwood, NY, U.S.A.). Individual CA1 pyramidal neurons were visually identified under infrared-differential interference contrast (IR-DIC) optics. Tight-seal, whole-cell, patch-clamp recording was performed using borosilicate glass electrodes (4-7 MO) backfilled with an intracellular pipette solution composed of: 140 mM K-gluconate, 10 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) (HEPES), 2 mM MgCl 2 , 1 mM CaCl 2 , 1 mM ethylene glycol-bis(baminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), and 2 mM K 2 ATP, pH = 7.25.
Cell culture and transient transfection
To study T-type calcium channels, 10 human Ca v 3.1 complementary DNA (cDNA) (Homo sapiens T calcium channel alpha 1G subunit variant 25, CACNA1G mRNA, complete cds, alternatively spliced) was expressed in tsA-201 human embryonic kidney (HEK) cells. HEK tsA-201 cells were grown to 80-90% confluence at 37°C (5% CO 2 ) in Dulbecco's modified Eagle's medium (Life Technologies, Grand Island, NY, U.S.A.), supplemented with 10% (vol/vol) fetal bovine serum (HyClone; Thermo Scientific, Pittsburgh, PA, U.S.A.), 200 U/ml penicillin, and 0.2 mg/ml streptomycin (Life Technologies). Cells were suspended with 0.25% trypsin/ethylenediaminetetraacetic acid and plated onto glass coverslips in 10-cm culture dishes (Corning, Corning, NY, U.S.A.) at 10% confluence 6 h before transfection. Calcium channel Ca v 3.1 (3 lg) and green fluorescent protein (GFP) marker (0.5 lg) DNAs were transfected into cells with calcium phosphate. Cells were transferred to 30°C 16-18 h later following transfection and stored for 2 days before recording.
Whole-cell electrophysiology
Cells on a glass coverslip were transferred into an external bath solution of 2 mM CaCl 2 , 1 mM MgCl 2 , 155 mM TEA-Cl, 2.5 mM 4-aminopyridine (4-AP), 10 mM HEPES, 10 mM glucose, pH 7.4. Borosilicate glass pipettes (Sutter Instrument Co., Novato, CA, U.S.A.) (3-5 MΩ) were filled with internal solution containing 140 mM CsCl, 2.5 mM CaCl 2 , 1 mM MgCl 2 , 5 mM EGTA, 10 mM HEPES, 2 mM Na-ATP and 0.3 mM Na-GTP, pH 7.3. Whole-cell patch clamp recordings were performed by using an EPC 10 amplifier (HEKA Elektronik, Bellmore, NY, U.S.A.) linked to a personal computer equipped with Pulse (V8.65) software (HEKA Elektronik). After seal formation, the membrane beneath the pipette was ruptured and the pipette solution was allowed to dialyze into the cell for 2-5 min before recording. Voltage-dependent currents were leak corrected with an online P/4 subtraction paradigm. Data were recorded at 10 kHz and filtered at 2.9 kHz. T-type calcium currents were elicited by depolarization from a holding potential of À110 mV to a test potential of À20 mV with an interpulse interval of 20 s. The duration of the test pulse was typically 40 msec. In current-voltage relation studies for Ca v 3.1, the membrane potential was held at À110 mV and cells were depolarized from À60 to +60 mV in 5 mV increments. In steady-state inactivation studies for Cav3.1, a 3 s conditioning prepulse of various magnitudes (initial holding at À110 mV) was followed by a depolarizing pulse to À20 mV. Individual sweeps were separated by 12 s to permit recovery from inactivation between conditioning pulses. The current amplitude obtained from test pulse was normalized to that observed at the holding potential of À110 mV.
Data analysis was performed by using online analysis built in Pulse software (HEKA Elektronik), and all graphs and curve fittings were prepared by using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, U.S.A.). Dose-response curves were fitted with the
n ), where A 1 is initial current amplitude and A 2 is the current amplitude at saturating drug concentrations, [C] is the drug concentration, and n is the Hill coefficient. Current-voltage relationships were fitted with the modified Boltzmann equation:
, where V m is the test potential, V 0.5act is the half activation potential, E rev is the reversal potential, G max is the maximum slope conductance, and j a reflects the slope of the activation curve. Steady-state inactivation curves were fitted using the Boltzmann equation:
, where V h is the half-inactivation potential and j is the slope factor.
Calcium imaging and cell viability assay
Hippocampal slices were incubated with the calcium indicator dye Fura2-AM (10 lM; Invitrogen) for 1 h. Each slice was transferred to a recording chamber fixed to an Axioskop FS2 IR-DIC microscope outfitted with the Zeiss Stallion 2 imaging system. Ratiometric fluorescence intensities in regions of interest were then recorded using a 340 nm/380 nm excitation filter set controlled by a high-speed filter switching device.
Photometric changes in fluorescence intensity (indicating alterations in free cytosolic [Ca 2+ ]), were recorded before, during, and after drug applications from CA3 pyramidal neurons every 10 s.
To assess calcium release from the ER, HEK293 cells were transfected with ryanodine receptor 2 (RyR2) cDNA using Ca 2+ phosphate precipitation, and intracellular Ca 2+ dynamics were measured as described previously. 11 Briefly, transfected HEK293 cells were grown on glass coverslips for up to 24 h, and then loaded with Fura2-AM (5 lM) in KRH (Krebs-Ringer-HEPES) buffer (125 mM NaCl, 5 mM KCl, 1.2 mM KH 2 PO 4 , 6 mM glucose, 1.2 mM MgCl 2 and 25 mM HEPES [pH = 7.4]) with 0.02% Pluronic F-127 and 0.1 mg/ml bovine serum albumin (BSA) for 20 min at room temperature (23°C). Coverslips with dye-loaded HEK293 cells were then transferred to a perfusion chamber on an inverted microscope (Nikon TE2000-S). The chamber was constantly perfused with KRH buffer containing 2 mM Ca 2+ , and time-lapse images (0.5 frames/s) were recorded on a PC and stored for offline analysis of fluorescence intensity using Compix Simple PCI 6 software (Compix Inc., Cranberry Township, PA, U.S.A.). Bath application of 2 mM Ca 2+ evoked an oscillatory Store Overload-Induced Calcium Release (SOICR) from the ER of HEK293 cells, and the resulting changes in fluorescence intensity were used to quantify the amplitude and frequency of the SOICR.
Neuroprotection assays
Murine hippocampal HT-22 cells were cultured with Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. HT-22 cells were seeded in 96-well cell culture plates (5,000 cells per well) and grown overnight. Cells were then treated with either media alone or CRS followed by the addition of glutamate. After a 24-h incubation, HT-22 cells were washed with phosphate-buffered saline (PBS) and loaded with 10 lM Fura2-AM for 1 h at 37°C. Loaded cells were washed twice with Dulbecco's phosphatebuffered saline (DPBS), and the intracellular calcium level was measured with a plate reader by successive excitation of 340 and 380 nm. The emitted fluorescence was passed through a 510 nm filter. Quantification of the [Ca 2+ ] was achieved by averaging the ratio of fluorescent signal acquired at 340 and 380 nm. To measure changes in cell survival against glutamate, 20 ll of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; 2.5 mg/ml) was added to the wells and incubated for 3 h. After incubation, the media was removed from the wells and 100 ll of dimethylsulfoxide (DMSO) was added to dissolve the formazan reagent. The absorbance was read using an Infinite m200 pro (TEKAN) reader at 565 nm. Cell viability was expressed as a percentage of the control group.
Mitochondrial isolation and mitochondrial membrane potential (DΨ) measurements
Our procedures were modified from previously described protocols. 12 Isolated brains were homogenized in isolation buffer and subsequently centrifuged at 1,300 g for 3 min at 4°C. The isolated supernatant was centrifuged at 13,000 g for 10 min at 4°C. The collected pellet was resuspended in 1.5 ml of isolation buffer with 0.01% digitonin and then centrifuged at 10,000 g for 10 min at 4°C. The pellet was resuspended in 500 ll of isolation buffer. For Ficoll purification, the gradient was made by first loading the Ficoll 10% solution in the ultracentrifuge tube and then adding the Ficoll 7.5% solution. Loaded samples on top of the Ficoll gradient were centrifuged at 32,000 À for 30 min at 4°C. The collected pellet was resuspended in isolation buffer without EGTA and spun at 10,000 g for 10 min at 4°C. The pellet was again resuspended in isolation buffer without EGTA, and then protein concentration was determined by a bicinchoninic acid protein assay kit.
DΨ was measured using the dye 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolyl carbocyanine iodide (MitoPT-JC1 kit; ImmunoChemistry Technologies). JC-1 emits green fluorescence at a low membrane potential (DΨ disruption), whereas polarized mitochondrial potentials reversibly form red fluorescent "J-aggregates" (DΨ stabilization). Briefly, aliquots of 250 lg of isolated mitochondrial protein were suspended in KCl respiration buffer (125 mM KCl, 2 mM MgCl, 2.5 mM KH 2 PO 4 , 20 mM HEPES, and 0.1% BSA [pH 7.2]) mixed with tested drugs and 10 lM JC-1 to make a final volume of 200 ll and then incubated at 37°C for 30 min. Fluorescence intensity was measured with a TECAN SpectraFluor Microplate Reader (TECAN) under excitation and emission wavelengths of 485 and 595 nm, respectively. Here, changes in red fluorescence intensities were indicative of DΨ and compared to the control optical density (OD) values.
Spectrofluorophotometer assays
Fractions enriched in mitochondria (200 lg protein/ ml) were placed in 2 ml of KCl respiration buffer within a temperature-controlled cuvette at 37°C with 100 nM CaG5 N (excitation 506 nm, emission 532 nm; to monitor extra-mitochondrial Ca 2+ ) and 150 nM tetramethyl rhodamine ethyl ester (excitation 550 nm, emission 575 nm; to monitor change in the mitochondrial membrane potential, Δw m ) in a Shimadzu RF-5301PC spectrofluorophotometer (Shimadzu, Tokyo, Japan). Each time-scan began with a baseline reading followed by the addition of 5 mmol/L pyruvate and 2.5 mmol/L malate at 1 min, 150 lmol/L ADP at 2 min, and 1 lmol/L oligomycin at 3 min. At 5 min, Ca 2+ was added via an infusion syringe pump (80 nmol Ca 2+ /mg protein per minute) until the mitochondria were no longer able to buffer the added Ca 2+ . The chemical uncoupler FCCP (1 lM; carbonyl cyanide-p-trifluoromethoxyphenylhydrazone) was added toward the end of the each run. The recorded traces, representative of at least three separate independent experiments, were quantified by calculating the average baseline CaG5 N fluorescence readings 1 min prior to the beginning of the Ca 2+ infusion using the Shimadzu Hyper RF software (Shimadzu) and Microsoft Excel. The time-point at which the CaG5 N signal was 150% above the average baseline reading was considered the point at which mitochondria were overloaded and no longer capable of removing Ca 2+ from the media, indicating the onset of mitochondrial permeability transition (mPT).
Drugs and statistical analysis
All reagents used in this study were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.) unless otherwise stated. Carisbamate (CRS) was obtained as a gift from Johnson & Johnson Pharmaceuticals and was dissolved in DMSO at various concentrations (but did not exceed 0.1%). Numerical data are expressed as the mean AE standard error of the mean (SEM). Student t-test or analysis of variance (ANOVA) was performed to determine differences among experimental groups, with significance set at p < 0.05.
Results
Carisbamate inhibits kainic acid-evoked epileptiform activity in vitro First, we assessed whether CRS diminishes kainic acid (KA)-evoked neuronal excitability in CA3 pyramidal neurons using acute hippocampal slices. Bath application of 10 lM KA induced long-lasting hyperexcitable changes superimposed on membrane depolarization (20 of 20 cells; Fig. 1A,D) . Upon application of KA in cells pretreated with 100 lM CRS, 8 of 20 cells did not exhibit neuronal hyperexcitability. This effect was sustained up to 20 min after washout (Fig. 1B-D) . The attenuation of sustained action potential discharge was more pronounced with 300 lM CRS (22 of 30 cells; Fig. 1C,D) .
The inhibitory effects of CRS were also examined with either Mg 2+ -free physiologic saline (which alleviates the Mg 2+ block of N-methyl-D-aspartate [NMDA] receptors) or 300 lM 4-aminopyridine (4-AP; a nonselective K + channel blocker and Ca 2+ channel activator). Under both of these experimental conditions, spontaneous rhythmic epileptiform discharges were seen, characterized by sustained overriding action potentials (Fig. 1E) . Consistent with antiseizure effects seen previously in cortical slices, 6 CRS (300 lM) blocked epileptiform discharges in both of these models (n = 7 cells/each study; Fig. 1E ). Fig. 2A ). Consistent with our initial electrophysiologic findings, pretreatment with 300 lM CRS produced a substantial reduction in [Ca 2+ ] i compared to cells treated solely with KA (n = 12; Fig. 2A) .
CRS reduces KA-mediated intracellular
We also reasoned that CRS would induce suppressive effects on zero-Mg 2+ -evoked epileptiform discharges. To confirm this, we measured glutamatemediated [Ca 2+ ] i accumulation in murine hippocampal HT-22 cells with and without CRS using Fura2-AM. In these cells, CRS alone (10 and 100 lM) had no influence on [Ca 2+ ] i levels, but both 5 and 10 mM glutamate dose-dependently increased the level of [Ca 2+ ] i compared to HT-22 cells exposed only to media (Fig. 2B) . When 5 mM glutamate was co-applied with either 10 lM or 100 lM CRS, the [Ca 2+ ] i level declined significantly by 19% (117 AE 5, n = 10) and 33% (104 AE 5.7, n = 10), respectively, compared to cells treated with 5 mM glutamate alone (136 AE 3.2, n = 10). No differences were seen with media alone, compared to 100 lM CRS plus 5 mM glutamate. At 10 mM glutamate (along with either 10 lM or 100 lM CRS), [Ca 2+ ] i levels were significantly reduced by 40% (131 AE 7.5, n = 10) and 54% (117 AE 6, n = 10), respectively, compared to cells treated with 10 mM glutamate alone (171 AE 6, n = 10) (Fig. 2B) . These data further support the notion that CRS contributes to an antiseizure action by decreasing pathologic [Ca 2+ ] i influx.
CRS prevents glutamate-induced neuronal injury
Next, we sought to determine whether the reduction in [Ca 2+ ] i by CRS could be correlated with morphologic neuroprotection. Using a live-cell imaging system, HT-22 cells exposed to 500 lM glutamate alone for 24 h resulted in a 40% decrease in cell viability (Fig. 3A) . However, cells treated concomitantly for 1 h with 100 lM CRS and 500 lM glutamate appeared healthy. One hundred micromolar CRS alone had no influence on cell survival (Fig. 3B) . Summary data of cell viability using the MTT assay for various treatment groups. Glu alone produced >40% cell death, and this effect was dose-dependently suppressed by CRS. Values represent group means AE SEM. One-way ANOVA followed by Tukey test; *p < 0.05. Epilepsia ILAE release, or SOICR) via the ryanodine receptor. 11 We next determined the impact of CRS on SOICR. There were no differences among groups treated with various CRS doses compared to controls, with respect to either the amplitude or frequency (n = 3-5 for each dose; Fig. 4A ). However, the SOICR amplitude in the 1 mM CRS-treated group was significantly lower compared to that seen when lower doses of CRS and DMSO (control) were used (Fig. 4B, p < 0.05) ; however, SOICR frequency was not changed with 1 mM CRS administration.
Next, we explored a potential modulatory effect of CRS on the mitochondrial membrane potential (Dw) or Ca 2+ -induced mPT. Acutely isolated hippocampal mitochondria were prepared, and exposed to CRS. We monitored the change in Dw from JC1-loaded isolated mitochondria treated with either 10 lM KA or 300 lM CRS for 30 min. Neither KA nor CRS separately altered Dw. In contrast, application of 100 nM rotenone (Rot), a toxic compound that acts by inhibiting complex I of the electron transport chain, triggered a significant decrease in DΨ (Fig. 5A , p < 0.01) as reported previously, 18 but 300 lM CRS had no effect on the Rot-evoked DΨ depolarization (Fig 5A) .
Given that a potential pathologic correlation exists between calcium overloading and mPT activation, we then asked whether CRS can regulate Ca 2+ -induced mPT. We found that CRS alone did not affect the threshold for Ca 2+ -induced mPT opening (Fig. 5B,C) .
CRS inhibits T-type Ca
2+ channels In the genetic absence epilepsy rat of Strasbourg (GAERS) model, CRS was found to strongly suppress spike-wave discharges. 19 Although there are many drugs that exhibit similar effects, the prototypic agent and firstline therapy for absence epilepsy, ethosuximide, is known to block low-threshold, T-type Ca 2+ channels, which play a pivotal role in the genesis of absence seizures in the thalamocortical network. [20] [21] [22] [23] To investigate the possibility that CRS interacts with T-type Ca 2+ channels, we performed whole-cell recordings in tsA-201 HEK cells expressing Ca v 3.1 channels. Fast-inactivating T-type currents, Despite a slight (but nonsignificant) reduction in the amplitude of store overload-evoked Ca 2+ oscillations over the CRS dose range of 30-300 lM, no significant differences were seen. However, at 1 mM CRS, the amplitude of the store overload-evoked oscillations was significantly suppressed by CRS (Student t-test; *p < 0.05). Epilepsia ILAE Figure 5 . Effects of carisbamate (CRS) in acutely isolated hippocampal mitochondria. (A) No differences in the mitochondrial membrane potential (Dw) were seen with either 300 lM CRS or 10 lM KA. After the addition of 100 nM rotenone (Rot), Dw dissipated substantially but this action was not prevented by CRS. One-way ANOVA followed by Tukey test; **p < 0.01. (B, C) Representative traces and summary data depicting Ca 2+ -induced mPT opening with and without CRS treatment. CRS (300 lM) did not affect mPT. Values represent mean AE SEM. Paired t-test was conducted between control and CRS-treated groups. Epilepsia ILAE generated by recombinant Ca v 3.1 channels, were generated in response to depolarizing pulses (Fig. 6) . With infusion of 100 lM CRS, a reduction in the T-type current was seen, with a peak effect when depolarized from À110 to À30 mV (Fig. 6A,B) . The current-voltage relationship of T-type Ca 2+ channel in response to CRS under different voltage steps revealed a significant decrease in whole-cell current amplitude across a wide range of voltages (Fig. 6C ). There was a significant shift in the half-inactivation potential upon application of 300 lM CRS (Fig. 6D) , indicating that this compound is able to stabilize the inactivated state of the channel. It is notable that this shift resulted in further inhibition of whole-cell current amplitudes at more depolarized membrane potentials. In additional experiments, we found no modulatory effects of 100 and 300 lM CRS on HEK cells transfected with Ca v 3.2 channels (n = 3; data not shown). Collectively, these results support our notion that the T-type Ca 2+ channel-specifically, the Ca v 3.1 isoform-is a target of CRS action, and may play an important role in regulating not only intracellular Ca 2+ , but also the antiseizure and neuroprotective effects seen with this novel antiseizure medication.
Discussion
In the present study, we show that CRS can inhibit KAinduced neuronal hyperexcitability, elevations in [Ca 2+ ] i , and subsequent hippocampal cell death in a dose-dependent manner. Although a direct mechanistic link to ryanodine receptors or to mitochondrial function could not be established, we nevertheless found that at a clinically relevant concentration, CRS (300 lM) could significantly attenuate T-type Ca 2+ currents in HEK cells transfected with recombinant Ca v 3.1 channels. Thus, after evaluating several major sources of calcium influx into the cell, we conclude from our data that the antiseizure and morphologic neuroprotective effects of CRS are likely due in part to blockade of T-type Ca 2+ channels. It is well known that KA-induced epileptogenesis is associated with activation of voltage-dependent calcium channels, 24, 25 which contributes to neuronal hyperexcitability and subsequent cell death. 13, 26 Our current findings are in keeping with the extensive prior literature, and more specifically with in vivo and in vitro experiments wherein CRS 2+ currents recorded before and after bath application of 300 lM CRS. There is a significant decrease in the peak amplitude of the current in response to a depolarizing step up from À110 to À30 mV. The remaining Ca v 3.1 current was 83.2 AE 1.9% (p = 0.02, paired t-test, n = 6) and 71.2 AE 4.2% (p = 0.00003, paired t-test, n = 6) after application of CRS at 100 and 300 lM, respectively. (B) Bar graph summarizing the peak Ca 2+ current amplitudes elicited with and without CRS (100 and 300 lM) treatment. (C) Current-voltage relationship for CRS block of Ca v 3.1. The half-activation potential from the fitted curves were À50.1 AE 0.4 mV and À51.2 AE 0.6 mV for before and after the application of CRS (300 lM, n = 6), respectively, p = 0.51 (paired t-test). (D) The steady-state inactivation curve for CRS block of Ca v 3.1. The half inactivation potential from the fitted curves were À62.6 AE 0.8 and À68.9 AE 1.0 for before and after the application of CRS (300 lM, n = 6), respectively, p = 0.0007 (paired t-test). Epilepsia was demonstrated to reduce seizure activity induced by KA. 27 Blockade of T-type calcium current constitutes a possible mechanism of action of CRS that augments inhibition of voltage-gated Na + channels, as evidenced by earlier studies revealing CRS's ability to decrease membrane input resistance and diminish action potential firing. 6, 7 With respect to neuronal injury, prolonged elevation in [Ca 2+ ] i following the activation of glutamate receptors is widely accepted as a key factor in the processes of both neuronal injury and epileptogenesis. 28 In this regard, our findings in the in vitro zero-Mg 2+ model (Fig. 1E ) are also consistent with the linkage between "seizure-like" epileptiform discharges and glutamate receptor-mediated calcium influx. 29 Furthermore, we show that CRS was able to exert effects against glutamate, similar to what was seen with KA exposure, specifically a normalization of [Ca 2+ ] i levels (Fig. 2) . This is consistent with the previously demonstrated inhibition of "seizure-like" rhythmic discharges in hippocampal slices bathed in zero-Mg 2+ artificial cerebrospinal fluid (aCSF). 6, 30 Excessive glutamate (specifically, NMDA) receptor activation, while impairing [Ca 2+ ] i homeostasis, can also facilitate release of Ca 2+ through ryanodine receptors (RyRs) from the ER. 31 Although there are compelling data indicating that CRS can suppress glutamate-mediated synaptic transmission in the granule cells of the dentate gyrus, 9 we could not confirm a direct effect of CRS on RyRs in the ER. However, it is likely that the inhibitory action of CRS on glutamate neurotransmission and blockade of T-type Ca 2+ channels can secondarily reduce the calcium burden on the ER.
The other major organelle to consider when studying intracellular calcium homeostasis is the mitochondrion. There is abundant evidence that mitochondria can act as a Ca 2+ buffer under conditions of NMDA-evoked increases in [Ca 2+ ] i , thereby helping to prevent neuronal injury or death. 32 However, when cellular homeostatic and compensatory systems fail to contain pathologic rises in [Ca 2+ ] i , or when excessive mitochondrial Ca 2+ accumulation occurs, cell death pathways are triggered via depolarization of Dw and opening of the mitochondrial permeability transition pore. 16, 17 In the present study, activation of kainate receptors elevated [Ca 2+ ] i in CA3 pyramidal neurons, but KA alone was unable to alter Dw in isolated mitochondria, suggesting that the pharmacologic actions of KA are likely upstream of the mitochondrion. Similarly, neither Dw nor Ca 2+ -induced mPT opening was affected after exposure to CRS. Despite the lack of direct interaction of CRS on mitochondria, we cannot exclude the possibility that the upstream modulation of [Ca 2+ ] i influx by CRS reduces overall mitochondrial Ca 2+ accumulation. It is well established that T-type Ca 2+ channels are critically involved in absence seizures [32] [33] [34] [35] [36] and that specific blockers of Ca v 3.1 exert antiseizure activity in both humans and animal models. 36, 37 Consistent with these data, we observed that Ca v 3.1 (but not Ca v 3.2) Ca 2+ currents were significantly attenuated by clinically relevant concentrations of CRS. We did not, however, evaluate the effects of CRS on high voltage-activated (HVA) calcium channels, as an earlier study indicated that selective HVA blockers were unable to reverse the inhibitory effect of CRS on a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-mediated excitatory postsynaptic currents. 9 Curiously though, unlike the prototypic T-type calcium channel blocker ethosuximide, CRS appears to have greater broadspectrum activity in multiple animal models of seizures and epilepsy, 38 suggesting other yet undefined mechanisms of action. 8, 9 To this point, CRS has been shown to inhibit glutamatergic neurotransmission in the dentate gyrus through an action potential-dependent mechanism, but not through presynaptic calcium channels. 9 In summary, we provide evidence that the antiseizure and neuroprotective effects of CRS may be explained partly on the basis of its ability to block T-type calcium channels in neurons, and also by preventing excessive intracellular calcium accumulation such as would occur through glutamate receptor activation. CRS also inhibits voltage-gated sodium channels, and there is recent evidence that this novel monocarbamate compound can modulate the activation of a c-aminobutyric acid (GABA)-mediated chloride conductance. 6, 7 Thus, with growing evidence that CRS may afford functional and neuroprotective-as well as disease-modifying-effects beyond epilepsy, the greater elucidation of basic mechanisms underlying these actions may lead to the development of analog compounds having similar profiles.
